
Hemolytic uremic syndrome (HUS) is a life-threatening disease characterised by hemolytic anemia, thrombocytopenia (low platelet count), gastrointestinal disturbances, and acute kidney failure. This disease is seen in children but can be more frequent in adults at high rates due to some pathogenic strains from infections derived from E. coli.
Causes
Risk Factors
The medical treatment of Hemolytic Uremic Syndrome in India adapts the newest research and technologies to meet worldwide clinical standards and healthcare capabilities.
The medical treatment for Hemolytic Uremic Syndrome requires evaluating the patient's severity and medical condition. The following are the treatment options:
Plasmapheresis : Plasma exchange is commonly utilised in atypical HUS (caused by genetic factors) or more severe disease cases. PEX is a process in which the patient's plasma is removed and replaced to filter toxins, complement proteins, and other detrimental substances.
Cost Start From USD 600 - USD 1500Explore Options
Blood transfusion: They may be necessary for patients suffering from HUS due to anemia and thrombocytopenia. Blood transfusions are performed to restore red blood cells and platelets, thus increasing oxygen supply and countering bleeding tendencies imposed by low platelet levels.
These are the standard diagnostic methods for diagnosing Hemolytic Uremic Syndrome:
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services designed to support patients in India. Additional services are as per the patient's requirement. These services include:
Treatment for Hemolytic Uremic Syndrome (HUS) includes plasma exchange along with antibiotics for E. coli infections in infectious cases. In the case of complications, steroids, antihypertensive medicines and dialysis are given. Blood transfusions are also performed in severe cases to combat anemia and thrombocytopenia.









Delhi, India
Manipal Hospital Dwarka is a leading multi-super speciality tertiary care hospital offering world-class, affordable, and accessible healthcare. Backed by renowned doctors, advanced technology, and global standards in clinical care, the hospital provides comprehensive preventive, diagnostic, and therapeutic services for all age groups. With 380 beds, 13 modular OTs, 118 critical care beds, and 24/7 emergency services, it combines excellence in patient care with innovations like AI, telemedicine, remote monitoring, and EMR—striving to become a fully digital, paperless hospital setting new standards in modern healthcare.

Gurgaon, India
Artemis Hospital, established in 2007 in Gurgaon, India, is a 750+ bed, state-of-the-art multi-speciality hospital and the first in Gurgaon accredited by JCI and NABH. A flagship of the Apollo Tyres Group, it offers advanced care across cardiology, oncology, orthopaedics, neurology, and transplant medicine, supported by modern infrastructure and 60+ world-class operating theatres. Its Centres of Excellence span critical areas like heart, cancer, neurosciences, orthopaedics, and women & child care. Guided by values of Service, Compassion, and Integrity, Artemis combines innovation, technology, and affordability, making it a trusted international healthcare destination for comprehensive and compassionate patient care.

Delhi, India
Max Super Speciality Hospital, Patparganj, a 400+ bed NABH-accredited facility under Balaji Medical and Diagnostic Research Centre, offers world-class care across 33+ specialties, including Cardiac Sciences, Oncology, Neurosciences, Orthopaedics, Obstetrics & Gynaecology, and Kidney Transplant. With 116 ICU beds, 14 HDU beds, 11 modular OTs, and an NABL-accredited Max Lab, the hospital ensures advanced, quality-driven care. Staffed by 510+ expert doctors and 770+ nurses, it’s India’s first AACI-accredited super speciality hospital and North & West India’s first QAI-accredited Advanced Brain Stroke Centre. Max Patparganj is a regional leader in complex surgeries, blending cutting-edge technology with compassionate, patient-centric healthcare.
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
The following are the much-growing reasons for India being frequented for Hemolytic Uremic Syndrome treatment:
HUS can affect individuals of all ages, but children under five and elderly adults are at higher risk. Those with weakened immune systems or genetic predispositions may also be more susceptible.
HUS can be prevented by practising good food safety (cooking meat thoroughly), maintaining hygiene (washing hands regularly), drinking clean water, and avoiding contact with infected individuals.
Some individuals may recover fully, but in severe cases, HUS can lead to chronic kidney disease or permanent kidney damage. Early treatment and monitoring are essential for minimising long-term complications.
While E. coli infection that causes HUS is contagious, HUS is not. However, those with E. coli infection should avoid close contact with others until cleared by a healthcare provider.
In cases of atypical HUS, there is a risk of recurrence, especially in individuals with genetic mutations affecting the complement system. Regular follow-up is essential for managing recurrence risks.
To prevent HUS, practise proper food hygiene, avoid undercooked meat, drink clean and filtered water, and ensure that dairy products are pasteurised. Boiling or treating water before consumption is crucial in areas with poor sanitation.
Genetic testing for atypical HUS (including mutations in the complement system) is available in some specialised hospitals and research centres, particularly in larger cities.
Children in India, especially those with a history of bloody diarrhoea, abdominal pain, and fever, should be monitored closely for HUS symptoms like fatigue, paleness, swelling, and decreased urine output. Early medical intervention can prevent kidney failure and other complications.
Survivors of HUS may need regular follow-up visits to monitor kidney function, manage potential chronic kidney disease (CKD), and monitor for hypertension or other complications. Supportive care may include a renal diet, blood pressure management, and physical therapy for muscle weakness.

Hematologist
9 Years of Experience
Dr. Akash Khandelwal is a distinguished Hematologist, Hemato-oncologist, and Bone Marrow Transplant (BMT) Physician with extensive training from the prestigious AIIMS New Delhi. His expertise encompasses a wide range of specialized techniques in bone marrow transplantation, including autologous and allogeneic transplants such as matched sibling donors, matched unrelated donors (MUD), and haploidentical donor transplants. Dr. Khandelwal has personally supervised and conducted over 100 bone marrow transplants. View More
Last Reviewed - January 2026